Diagnostic Approach to Prolonged Pediatric Fevers

Infectious Causes

• The American Academy of Pediatrics recommends that urinary tract infections be considered in febrile children, with a prevalence of 3-7% in children with fever without source, and higher rates in girls (8.1% ages 1-2 years) and uncircumcised boys (8-12.4% in infants) 1, 2
• Bacterial meningitis risk varies by age, but overall incidence has decreased with vaccination, according to the Centers for Disease Control and Prevention 2, 3
• The presence of one viral infection does not preclude coexisting bacterial infection, as noted by the American Academy of Pediatrics 2
• Herpes simplex virus can have devastating consequences in young infants, according to the American Academy of Pediatrics 2

Inflammatory/Rheumatologic Causes

• The American Heart Association recommends that Kawasaki Disease be considered in children with prolonged fever (≥5 days) as the hallmark feature, with a risk of coronary artery aneurysms increasing significantly if treatment is delayed beyond 10 days of fever onset 4, 5
• Incomplete Kawasaki Disease occurs most commonly in infants, who may have prolonged fever as the sole or primary finding with subtle or fleeting additional signs, according to the American Heart Association 4
• The American College of Rheumatology notes that Multisystem Inflammatory Syndrome in Children (MIS-C) is temporally associated with SARS-CoV-2 infection (2-6 weeks post-exposure), with children presenting with significantly higher temperatures and longer fever duration than routine pediatric illnesses 6, 7

Neoplastic Causes

• The American Cancer Society notes that malignancies account for a portion of pediatric FUO cases, with leukemia or lymphoma requiring CBC with differential to assess for cytopenias, thrombocytopenia, abnormal cells 8

Diagnostic Approach

• The American Academy of Pediatrics recommends urinalysis and urine culture (catheterized specimen, NOT bag specimen) as part of the initial evaluation for prolonged fever 9
• The American Academy of Pediatrics also recommends complete blood count with differential, blood culture (before antibiotics), inflammatory markers (CRP, ESR, procalcitonin), and comprehensive metabolic panel including liver function tests as part of the initial evaluation 9, 8
• The American Heart Association recommends urgent echocardiography for children with suspected Kawasaki Disease 4, 5

Age-Specific Risk Stratification

• The American Academy of Pediatrics notes that neonates (0-28 days) are at highest risk for serious bacterial infection (SBI), with a 13% incidence, and require comprehensive evaluation including lumbar puncture for CSF analysis 2, 3
• The American Academy of Pediatrics also notes that young infants (29-90 days) have a 9% incidence of SBI and may be risk-stratified using validated criteria (Rochester or Philadelphia criteria) 2

Prognosis and Outcomes

• The American Academy of Pediatrics notes that approximately 50% of children with true FUO will have self-limited illness and never receive a specific diagnosis, while the other 50% will ultimately be diagnosed with infectious, inflammatory, or neoplastic conditions 1, 2
• The American Heart Association notes that delayed diagnosis of Kawasaki Disease beyond 10 days of fever onset significantly increases the risk of coronary artery aneurysms 4, 5
• The American Academy of Pediatrics notes that UTI with pyelonephritis has a 27-64% risk of renal scarring, with potential for hypertension (10-20%) and end-stage renal disease (10%) later in life 1

Prolonged Fever Diagnosis and Management

Infectious Causes

• Q fever (Coxiella burnetii) can present as chronic infection with phase I IgG titers ≥1:1024, particularly in patients with valvular heart disease or vascular abnormalities, according to the Centers for Disease Control and Prevention (CDC) 10, 11
• Katayama syndrome (acute schistosomiasis) presents 4-6 weeks after freshwater exposure with fever, eosinophilia, and urticarial rash, as reported by the World Health Organization (WHO) 12
• Bacterial endocarditis must be excluded in patients with cardiac risk factors, as recommended by the American Heart Association (AHA) 11

Inflammatory/Rheumatologic Diseases

• Kawasaki disease requires fever for ≥5 days plus 4 of 5 criteria: bilateral conjunctival injection, oral mucosal changes, polymorphous rash, extremity changes, cervical lymphadenopathy ≥1.5 cm, according to the American Academy of Pediatrics (AAP) 13, 14, 15
• Kawasaki disease diagnosis can be made on day 4 of fever if 4 principal criteria are present, as stated by the American College of Cardiology (ACC) 13, 14

Miscellaneous Causes

• Drug-induced fever occurs with a mean lag time of 21 days (median 8 days) after drug initiation and can take 1-7 days to resolve after discontinuation, as reported by the Society of Critical Care Medicine (SCCM) 16
• Drug fever can be caused by any medication through hypersensitivity; rash and eosinophilia are uncommon, according to the American Medical Association (AMA) 16
• Neuroleptic malignant syndrome from antipsychotics (especially haloperidol in ICU settings) presents with muscle rigidity and elevated creatinine phosphokinase, as warned by the FDA 16
• Malignant hyperthermia from anesthetics can have delayed onset up to 24 hours, as cautioned by the American Society of Anesthesiologists (ASA) 16

Diagnostic Workup

• Inflammatory markers (CRP, ESR, procalcitonin) help distinguish infectious from non-infectious causes, as recommended by the Infectious Diseases Society of America (IDSA) 16
• Q fever serologies (phase I and II IgG/IgM) should be performed if epidemiologic risk factors are present, as suggested by the CDC 10, 11

Special Populations

• Immunocompromised patients require broader infectious workup including opportunistic pathogens, as recommended by the IDSA 11
• Cardiac risk factors (valvular disease, prosthetic valves, vascular grafts) necessitate endocarditis evaluation and Q fever serologies, as advised by the AHA 10, 11

Prognosis

• Q fever patients with valvular defects remain at lifelong risk for chronic infection recrudescence, as reported by the CDC 10, 11

Diagnostic Approach for Pediatric Patients with Prolonged Symptoms

Initial Evaluation and Risk Stratification

• The American Academy of Pediatrics recommends that children with prolonged fever, lymphadenopathy, and cytopenias should undergo immediate peripheral blood film examination and complete blood count with differential to rule out acute lymphoblastic leukemia, with a high index of suspicion if lymph nodes are larger than 2 cm, hard, or matted, or if hepatosplenomegaly is present with cytopenias 17
• Chest radiograph should be performed if respiratory symptoms or mediastinal lymphadenopathy is suspected, as part of the initial evaluation to rule out other causes of symptoms, such as tuberculosis or pneumonia, in pediatric patients with prolonged symptoms 18
• Echocardiography should only be performed if Kawasaki disease criteria are met, which is unlikely in pediatric patients with low-grade fever and 2-month duration of symptoms, but should be considered if there are signs of cardiac involvement 19

Laboratory Testing and Diagnostic Approach

• The diagnostic approach for pediatric patients with prolonged symptoms should include virology screening, such as Epstein-Barr virus, influenza, and SARS-CoV-2 testing, but should not delay bone marrow examination if malignancy is suspected, as the presence of one viral infection does not preclude coexisting bacterial infection or malignancy 17
• Bone marrow examination is crucial for the definitive diagnosis of acute lymphoblastic leukemia and should be performed immediately if blasts are present on peripheral blood film, or if unexplained cytopenias persist, with a high index of suspicion if lymph nodes are larger than 2 cm, hard, or matted, or if hepatosplenomegaly is present with cytopenias 18
• The strength of evidence for the diagnostic approach is based on the clinical presentation and laboratory findings, with a high index of suspicion for malignancy if lymph nodes are larger than 2 cm, hard, or matted, or if hepatosplenomegaly is present with cytopenias, and the diagnostic approach should be guided by the clinical judgment of the healthcare provider 19

Diagnostic Approach to Prolonged Fever

Initial Evaluation

• Blood cultures should be taken in multiple sets before any antibiotics to identify bacteremia, as recommended by the European Society of Cardiology 20, 21
• Echocardiography should be performed if cardiac risk factors exist to exclude endocarditis, with transoesophageal echocardiography having superior sensitivity over transthoracic imaging, according to the American Heart Association 21, 22
• High-resolution CT or ultrasonography should be used for suspected deep-seated infections, such as abscesses or sinusitis, as suggested by the Infectious Diseases Society of America 23

Management of Fever

• Empirical antimicrobial therapy is warranted in unstable or deteriorating patients, with coverage for resistant gram-negative, gram-positive, anaerobic bacteria, and fungi, as recommended by the Infectious Diseases Society of America 24, 23
• Vancomycin should only be added for documented gram-positive infection, suspected catheter-related infection, or persistent fever with clinical deterioration, according to the Infectious Diseases Society of America 24, 23

Diagnostic Pitfalls

• Therapeutic errors, such as adding vancomycin empirically without specific indications, can promote resistance, as warned by the Infectious Diseases Society of America 24, 23
• Discontinuing evaluation prematurely in stable patients can lead to missed diagnoses, as serial assessments often reveal evolving signs, according to the Infectious Diseases Society of America 23

Management of Pediatric Patient with Prolonged Fever

Initial Evaluation and Risk Stratification

• The American Academy of Pediatrics emphasizes that both abnormal urinalysis AND positive culture are needed to confirm urinary tract infection 25, 26
• The overall prevalence of urinary tract infection in febrile children 2-24 months without apparent source is approximately 5%, but specific risk factors substantially increase this likelihood 25, 26, 27
• For girls, the probability of urinary tract infection exceeds 2% with more than 2 risk factors present, including age <12 months, white race, temperature ≥39°C, fever ≥2 days, and absence of another infection source 25, 26
• For boys, uncircumcised status, nonblack race, temperature ≥39°C, and fever >24 hours increase the risk of urinary tract infection 25, 26

Diagnostic Approach

• If risk factors are present, obtain a catheterized urine specimen for culture immediately, even with normal prior urinalysis 27, 25, 28
• The American Academy of Pediatrics recommends reassessing the likelihood of urinary tract infection using clinical risk factors and obtaining repeat catheterized urine culture if risk factors are present 25, 26

Clinical Follow-Up

• Reassess within 24-48 hours if fever persists, and instruct the family to return immediately for ill appearance, worsening fever, new symptoms, or inability to maintain hydration 27, 25, 28
• Ensure urine testing with subsequent febrile illnesses to catch delayed urinary tract infection presentations 28

Diagnostic Considerations

• Do not rely solely on bag-collected urine specimens, as they cannot establish urinary tract infection diagnosis reliably due to contamination 27, 25, 26
• Do not assume normal urinalysis excludes urinary tract infection - obtain culture if clinical risk factors are present 25, 26

Diagnostic Approach for Pediatric Patients with Prolonged Symptoms

Initial Priority: Rule Out Malignancy First

• The National Comprehensive Cancer Network recommends that a 2-month duration of symptoms with pallor, lethargy, and lymphadenopathy raises immediate concern for acute lymphoblastic leukemia or lymphoma in pediatric patients, and lactate dehydrogenase (LDH) is often markedly elevated in lymphoma and leukemia 29
• Excisional or incisional lymph node biopsy with fresh tissue sent in saline is preferred for lymphoma diagnosis, with morphology and flow cytometry as minimum methodologies, according to the National Comprehensive Cancer Network 29

Diagnostic Approach to Suspected Hematologic Malignancy

Introduction to Diagnostic Guidelines

• The American Society of Hematology guidelines suggest that bone marrow examination is necessary for diagnosing hematologic malignancies, such as acute lymphoblastic leukemia (ALL) or lymphoma, in patients with atypical features like lymphadenopathy, fever, and prolonged course of symptoms 30, 31, 32

Diagnostic Tests and Procedures

• Bone marrow examination has a diagnostic yield of 23.7% in cases of prolonged fever, and this yield increases significantly when thrombocytopenia or anemia are present, according to the Blood journal 30
• Peripheral blood film examination may miss bone marrow-based malignancies in early stages or when circulating blasts are absent, highlighting the importance of bone marrow examination 30
• Platelet antibodies testing is not relevant for diagnosing conditions with lymphadenopathy, prolonged fever, or 2-month duration of symptoms, as stated in the Blood journal 30, 31, 32

Immediate Evaluation of Infants with ≥5‑Day Fever for Kawasaki Disease and Urinary Tract Infection

Diagnostic Priorities

Kawasaki Disease Clinical Criteria

33, 35

Laboratory and Imaging Recommendations

Critical Pitfalls

Kawasaki Disease in Children with Fever and Rash

Epidemiology & Risk of Delayed Treatment

• In children with unexplained fever lasting ≥5 days, postponing treatment beyond 10 days markedly raises the risk of coronary artery aneurysm, with incidence falling from roughly 25 % to about 5 % when therapy is started promptly. 39

Diagnostic Criteria

Classic Presentation

• Classic Kawasaki disease is diagnosed when a child has fever ≥5 days plus at least four of the following five features:
  These criteria are derived from the American Family Physician guidance. 39

Incomplete Presentation (Infants < 1 year)

• In infants younger than 12 months, incomplete Kawasaki disease is common and carries a higher likelihood of coronary complications. 39

Laboratory Evaluation for Incomplete Cases

• When fever ≥5 days is accompanied by only 2–3 clinical features, an erythrocyte sedimentation rate (ESR) ≥40 mm/hr and/or C‑reactive protein (CRP) ≥3 mg/dL should trigger a full work‑up—including complete blood count, metabolic panel (albumin, transaminases), urinalysis, and urgent echocardiography. 39

• Coronary artery abnormalities identified on echocardiography allow a diagnosis of Kawasaki disease even if only three clinical features are present. 39

Treatment Recommendations

• Intravenous immunoglobulin (IVIG) 2 g/kg administered as a single infusion is the first‑line therapy.
• High‑dose aspirin 80–100 mg/kg/day, divided into four doses, is given concurrently.
• Therapy must be initiated within 10 days of fever onset to effectively prevent coronary artery complications. 39

Age‑Specific Management

• For any child younger than 12 months with fever ≥5 days, clinicians should obtain an urgent echocardiogram even when only minimal clinical features are evident, due to the heightened risk of coronary involvement. 39

Laboratory and Imaging Recommendations for Pediatric Patients with Fever ≥ 5 Days

Blood Culture Evaluation

• Obtain a peripheral blood culture before initiating antibiotics to detect bacteremia in any child with fever lasting five days or more. This helps identify serious bacterial infection early and guide antimicrobial therapy. Evidence level not specified. 40

Lumbar Puncture Considerations in Young Infants

• In infants 1–3 months old presenting with fever of five days or longer, a lumbar puncture should be considered when the infant appears ill or exhibits concerning clinical features (e.g., irritability, poor feeding, abnormal vital signs). This approach aims to rule out meningitis in a population with a notable risk of serious bacterial infection. Evidence level not specified. 41, 42

Chest Radiography Indications

• Perform a chest radiograph only when respiratory symptoms are present (such as cough, wheeze, or dyspnea) in children with prolonged fever. Routine imaging in well‑appearing patients without respiratory signs is not recommended. Evidence level not specified. 41

Kawasaki Disease Evaluation and Management in Children

Diagnostic Criteria

• The American College of Cardiology (as cited in American Family Physician) defines classic Kawasaki disease as fever lasting ≥5 days plus at least four of the five principal clinical features (bilateral non‑purulent conjunctival injection, oral mucosal changes, polymorphous rash, extremity changes, cervical lymphadenopathy ≥1.5 cm)【43】.
• Incomplete Kawasaki disease may be diagnosed as early as day 4 when four principal features are present, or when coronary artery abnormalities are identified on echocardiography despite only three clinical features【43】.

Targeted Physical Examination

• Examine the conjunctivae for bilateral injection without exudate【43】.
• Inspect the lips for cracking and the tongue for a “strawberry” appearance【43】.
• Look for a polymorphous rash, often accentuated in the groin【43】.
• Assess the hands and feet for erythema or edema with sharp demarcation at the wrists/ankles【43】.
• Palpate the neck for cervical lymph nodes ≥1.5 cm in diameter【43】.
• Evaluate overall hydration status and general appearance【44】.

Laboratory Evaluation (when Kawasaki disease is suspected)

• Obtain inflammatory markers immediately:
  
  • Erythrocyte sedimentation rate (ESR) ≥ 40 mm/hr (often >100 mm/hr) supports the diagnosis【43】.
  • C‑reactive protein (CRP) ≥ 3 mg/dL is consistent with Kawasaki disease【43】.
• Perform a complete blood count with differential to identify neutrophilia, lymphopenia, and (later) thrombocytosis【43】.
• Conduct a comprehensive metabolic panel, including albumin and liver transaminases; hypoalbuminemia is a common finding【43】.

Cardiac Imaging

• Obtain an urgent transthoracic echocardiogram when ≥ 2 principal Kawasaki disease features are present with fever, even before day 5, to evaluate for coronary artery changes (perivascular brightness, ectasia, lack of tapering, pericardial effusion)【43】.

Management Algorithm

Days 1‑2 (initial presentation)

• Perform a meticulous examination for all five principal features【43】.
• If ≥ 2 features are identified, order the laboratory panel (ESR, CRP, CBC, CMP) and obtain an urgent echocardiogram【43】.

Days 3‑4 (follow‑up)

• Re‑assess daily for the emergence of additional Kawasaki disease features【43】.

Day 5 + (definitive diagnosis and treatment)

• When fever persists to day 5 and ≥ 4 principal features are present, confirm a definitive Kawasaki disease diagnosis【43】.
• Initiate intravenous immunoglobulin (IVIG) 2 g/kg as a single infusion【43】.
• Start high‑dose aspirin 80‑100 mg/kg/day divided into four doses【43】.

Important Differential Consideration

• Multisystem Inflammatory Syndrome in Children (MIS‑C) should be considered when there is a history of COVID‑19 exposure 2‑6 weeks prior and the fever is higher and more prolonged than typical Kawasaki disease【45】.

Parent Education & Safety‑Netting

• Advise caregivers to seek immediate care if the child develops new conjunctival redness, lip cracking, swelling of the hands/feet, or cervical lymphadenopathy【43】.
• Explain that Kawasaki disease remains a possibility and requires close monitoring over the next several days【43】.

Imaging and Invasive Procedure Recommendations for Febrile Infants

Chest Radiography

• In well‑appearing infants without respiratory signs (e.g., cough, hypoxia, rales, or disproportionate tachypnea), routine chest radiography is not indicated. 46
• Prospective studies in this age group demonstrate that the diagnostic yield of chest radiography is less than 3 % when no respiratory symptoms are present. 46

Lumbar Puncture

• Routine lumbar puncture is not recommended for infants around 9 months of age unless they exhibit concerning features such as toxic appearance, altered mental status, or focal neurologic deficits. 46
• The incidence of bacterial meningitis in infants of this age is significantly lower than in the neonatal period, supporting a more selective approach to cerebrospinal fluid sampling. 46